Menu
  • Join
  • Login
  • Contact
 

Search abstracts


MEDICATION PREFERENCES OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) PATIENTS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: ARAJA, Diana (Latvia)
  • Co-author(s): Diana Araja: Riga Stradins University, Riga, Latvia
    Elenka Brenna: Università Cattolica del Sacro Cuore, Rome, Italy
    Derek Pheby: Buckinghamshire New University, London, United Kingdom
    Uldis Berķis: Riga Stradins University, Riga, Latvia
    Asja Lunga: Riga Stradins University, Riga, Latvia
    Modra Murovska: Riga Stradins University, Riga, Latvia
  • Abstract:

    Background

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system disorder, which lead to substantial reductions in functional activity and quality of life. There are no Europe-wide prevalence data, but it is estimated that there are some two million sufferers in Europe as a whole.

    Methods

    To achieve the goal of this research,

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses